
Fischer Medical (FISCHER) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
234.4M
Gross Profit
106.8M
45.56%
Operating Income
34.9M
14.89%
Net Income
50.1M
21.36%
EPS (Diluted)
₹0.01
Balance Sheet Metrics
Total Assets
4.6B
Total Liabilities
1.2B
Shareholders Equity
3.4B
Debt to Equity
0.35
Cash Flow Metrics
Revenue & Profitability Trend
Fischer Medical Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.1B | 209.8M | 1.8M | 0 | 1.6M |
Cost of Goods Sold | 915.9M | 164.5M | 0 | - | 0 |
Gross Profit | 191.1M | 45.3M | 1.8M | - | 1.6M |
Gross Margin % | 17.3% | 21.6% | 100.0% | 0.0% | 100.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 53.6M | 5.8M | 367.0K | 230.0K | 91.0K |
Other Operating Expenses | 55.5M | 16.2M | 576.0K | 615.0K | 715.0K |
Total Operating Expenses | 109.1M | 22.0M | 943.0K | 845.0K | 806.0K |
Operating Income | 30.6M | 16.5M | 153.0K | -1.9M | -176.0K |
Operating Margin % | 2.8% | 7.9% | 8.5% | 0.0% | -10.7% |
Non-Operating Items | |||||
Interest Income | 9.3M | 5.0M | 0 | - | - |
Interest Expense | 4.0M | 676.0K | 165.0K | 87.0K | 180.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 22.2M | 21.1M | -13.0K | -2.0M | -356.0K |
Income Tax | 10.1M | 2.7M | 352.0K | 352.0K | -1.8M |
Effective Tax Rate % | 45.7% | 12.9% | 0.0% | 0.0% | 0.0% |
Net Income | 12.1M | 18.4M | -365.0K | -2.3M | 1.4M |
Net Margin % | 1.1% | 8.8% | -20.3% | 0.0% | 85.2% |
Key Metrics | |||||
EBITDA | 53.5M | 23.4M | 152.0K | -1.9M | -176.0K |
EPS (Basic) | ₹0.01 | ₹1.65 | ₹-2.12 | ₹-13.52 | ₹8.18 |
EPS (Diluted) | ₹0.01 | ₹1.08 | ₹-2.12 | ₹-13.52 | ₹8.18 |
Basic Shares Outstanding | 1452090000 | 11124000 | 172000 | 172000 | 172000 |
Diluted Shares Outstanding | 1452090000 | 11124000 | 172000 | 172000 | 172000 |
Income Statement Trend
Fischer Medical Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.0B | 9.5M | 358.0K | 156.0K | 449.0K |
Short-term Investments | 1.5B | 370.0M | 50.0K | 50.0K | 50.0K |
Accounts Receivable | 760.7M | 228.7M | 1.7M | 0 | - |
Inventory | 91.6M | 44.8M | 0 | - | - |
Other Current Assets | 1.1M | 20.6M | -1.0K | 287.0K | 275.0K |
Total Current Assets | 3.7B | 704.1M | 2.5M | 493.0K | 774.0K |
Non-Current Assets | |||||
Property, Plant & Equipment | 89.0M | 60.6M | - | - | - |
Goodwill | 105.5M | 44.3M | 0 | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 6.2M | - | - | - | - |
Total Non-Current Assets | 920.8M | 159.2M | 1.1M | 1.4M | 1.8M |
Total Assets | 4.6B | 863.2M | 3.5M | 1.9M | 2.5M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 206.5M | 21.6M | 141.0K | 68.0K | 35.0K |
Short-term Debt | 681.7M | 4.3M | 0 | 3.9M | 0 |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 116.6M | 2.0M | -1.0K | -1.0K | 31.0K |
Total Current Liabilities | 1.0B | 38.3M | 478.0K | 4.2M | 177.0K |
Non-Current Liabilities | |||||
Long-term Debt | 172.1M | 12.5M | 5.7M | 0 | 2.3M |
Deferred Tax Liabilities | 3.9M | 1.2M | 0 | - | - |
Other Non-Current Liabilities | - | 1.0K | - | - | - |
Total Non-Current Liabilities | 176.8M | 13.8M | 5.7M | 0 | 2.3M |
Total Liabilities | 1.2B | 52.1M | 6.2M | 4.2M | 2.5M |
Equity | |||||
Common Stock | 638.0M | 535.0M | 1.7M | 1.7M | 1.7M |
Retained Earnings | 29.0M | 12.5M | -5.9M | -5.5M | -3.2M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 3.4B | 811.1M | -2.7M | -2.3M | 31.0K |
Key Metrics | |||||
Total Debt | 853.7M | 16.8M | 5.7M | 3.9M | 2.3M |
Working Capital | 2.6B | 665.7M | 2.0M | -3.7M | 597.0K |
Balance Sheet Composition
Fischer Medical Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 22.2M | 21.1M | -13.0K | -2.0M | -356.0K |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -1.0B | -196.0M | -1.7M | 85.0K | -149.0K |
Operating Cash Flow | -1.0B | -174.5M | -1.5M | -1.8M | -325.0K |
Investing Activities | |||||
Capital Expenditures | -59.9M | -3.0M | 0 | 0 | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | -1.2B | -309.0M | 0 | 0 | - |
Investment Sales | - | - | 0 | 0 | - |
Investing Cash Flow | -1.3B | -312.0M | 0 | 0 | - |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | 1.7M | 1.5M | 0 |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 2.6B | 382.8M | 1.7M | 1.5M | -14.0K |
Free Cash Flow | -927.3M | -78.9M | -1.5M | -1.8M | -573.0K |
Net Change in Cash | 276.6M | -103.7M | 126.0K | -326.0K | -339.0K |
Cash Flow Trend
Fischer Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
1,197.22
Price to Book
35.60
Price to Sales
55.67
PEG Ratio
-8.26
Profitability Ratios
Profit Margin
5.26%
Operating Margin
14.89%
Return on Equity
0.36%
Return on Assets
0.26%
Financial Health
Current Ratio
3.59
Debt to Equity
25.27
Beta
-0.00
Per Share Data
EPS (TTM)
₹0.09
Book Value per Share
₹3.03
Revenue per Share
₹0.76
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
fischer | 69.7B | 1,197.22 | 35.60 | 0.36% | 5.26% | 25.27 |
HSIL Limited | 53.7B | 18.70 | - | 1,493.74% | 72.43% | 89.90 |
Universus Photo | 2.9B | 3.44 | 0.32 | 9.95% | 402.80% | 0.00 |
Nureca | 2.4B | 306.06 | 1.19 | 0.44% | 0.00% | 2.56 |
Maestros Electronics | 779.5M | 16.62 | 2.22 | 12.54% | 15.18% | 10.31 |
Opto Circuits | 541.1M | -0.04 | -0.22 | 1,590.30% | 57.24% | -4.06 |
Financial data is updated regularly. All figures are in the company's reporting currency.